OrthoPediatrics Corp.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from OrthoPediatrics Corp.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: For every $100 of sales, $71 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $69 tied up three years earlier. More money tied up than 98% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-1.4×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 60% of Healthcare companies in United States.
Cash Locked Ratio
$71For every $100 of sales, $71 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $69 tied up three years earlier.
More money tied up than 98% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 0/3Sales grew in 3 of the last 3 years; profit grew in 0 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
−$36Sales grew 93% in 3 years, but profit fell: $36 less profit per $100 of extra sales.
Lower than 80% of Healthcare companies in United States.
Asset Productivity Ratio
+93% / +19%In 3 years sales changed by +93% while total assets changed by +19%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-28.5×Operating cash was negative last year, while some debt falls due within a year.
Lower than 62% of Healthcare companies in United States.
Cash Cushion Ratio
−6%Debt, after subtracting cash, equals 6% of its market value (net debt).
Lower than 75% of Healthcare companies in United States.
Tangible Assets Ratio
63%Of every $100 the company owns, $63 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 67% of Healthcare companies in United States.
Tangible Net Worth Ratio
46%Of every $100 of net worth, $46 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 54% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
OrthoPediatrics Corp. made a loss over the last year. OrthoPediatrics Corp. owes $0.33 for every $1 it owns. OrthoPediatrics Corp. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossOrthoPediatrics Corp. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.88The share price is 1.88 times OrthoPediatrics Corp.'s book value per share, lower than 61% of Healthcare companies in United States.
Market cap
$645 MThe total market value of all of OrthoPediatrics Corp.'s shares at today's price (share price × number of shares), larger than 58% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$344 MWhat OrthoPediatrics Corp. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$13.16Net worth divided by the number of shares. The share price of $24.71 is 1.9 times this, which is the P/B above.
Return on equity (ROE)
-11.4%OrthoPediatrics Corp. lost 11.4% of its shareholders' money over the last year, higher than 70% of Healthcare companies in United States.
Owes vs Owns
0.33×OrthoPediatrics Corp. owes $0.33 for every $1 it owns (low), lower than 57% of Healthcare companies in United States.
Dividend yield
NoneOrthoPediatrics Corp. does not currently pay a dividend.
Revenue growth
+15%Revenue rose 15% in the year to Dec 2025, and grew 25% a year on average over 3 years.
Profit growth
LossOrthoPediatrics Corp. made a loss in each of the last two years.
Profit margin
-16.8%OrthoPediatrics Corp. lost $17 for every $100 of revenue.
Cash vs debt
Net debtOrthoPediatrics Corp. had $39 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For OrthoPediatrics Corp.: $645 M ÷ $344 M (30 Jun 2026) = 1.9.
What is OrthoPediatrics Corp.'s return on equity?
OrthoPediatrics Corp. lost 11.4% of its shareholders' money over the last year, higher than 70% of Healthcare companies in United States.
How much does OrthoPediatrics Corp. owe compared with what it owns?
OrthoPediatrics Corp. owes $0.33 for every $1 it owns (low), lower than 57% of Healthcare companies in United States.
Does OrthoPediatrics Corp. pay a dividend?
No. OrthoPediatrics Corp. does not currently pay a dividend.
Is OrthoPediatrics Corp.'s revenue growing?
Revenue rose 15% in the year to Dec 2025, and grew 25% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.